Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Akorn gets FDA warning letter for Illinois plant

Akorn Inc. received a warning letter from the U.S. Food and Drug Administration following an inspection of the generic drugmaker’s Decatur, Illinois manufacturing plant during 2018.

Read More »

Akorn shares fall after Delaware court rules in favor of Fresenius

The Delaware Supreme Court said in a court filing that Germany’s Fresenius SE properly terminated the company’s merger agreement with Akorn Inc., sending shares of the U.S generic drugmaker down more than 30 percent.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!

Subscribe

Ad Right Bottom